Head-to-head · Cost-Efficiency Index
NiceRx vs Amble
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
NiceRx
Cost-first shoppers who want a clearly disclosed standing month-to-month rate rather than a prepay-gated one.
Visit NiceRxAmble
Cost-first shoppers who want a single flat rate across semaglutide and tirzepatide, if a 12-month prepay is acceptable.
Visit AmbleThe verdict
NiceRx takes it, leading the Cost-Efficiency Index 76 to 74. NiceRx is a compounded GLP-1 telehealth platform charging $199/mo for semaglutide and $299/mo for tirzepatide on an ongoing month-to-month basis (first month discounted to $99 and $199 respectively). Amble still earns a C — Cost-first shoppers who want a single flat rate across semaglutide and tirzepatide, if a 12-month prepay is acceptable.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs NiceRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | NiceRx | Amble |
|---|---|---|
| Cost-Efficiency Index | 76/100 | 74/100 |
| Semaglutide / mo | $199/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Tirzepatide / mo | $299/mo (all doses, compounded) | $179/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,388 | $2,148 |
| Tirzepatide / yr (modeled) | $3,588 | $2,148 |
| Coverage | 46 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #50 | #56 |
NiceRx
76/100Where the value is
- Explicitly discloses both the promotional first-month price and the real ongoing 'every month thereafter' rate on the same page, rather than only advertising the promo
- Flat pricing across all doses, with the provider visit and shipping bundled into the price
- Cancel-anytime billing with no long-term commitment structure found
The tradeoffs
- Not available in Alaska, Mississippi, New Jersey, or Kansas
- Compounded only — no FDA-approved brand option
Amble
74/100Where the value is
- No difference in price between semaglutide and tirzepatide — genuinely one pricing table for both
- True no-commitment option exists ($179/mo, pay as you go) alongside the prepay tiers
- All 50 states, with only 5 requiring a live video visit instead of async intake
The tradeoffs
- The advertised low-end price ($135-$160/mo) is not a monthly bill — it's a one-time lump-sum prepay for the whole 3/6/12-month term, stated explicitly on the page
- No named medical director, prescriber, or compounding pharmacy anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.